Glycodelin A is a prognostic marker to predict poor outcome in advanced stage ovarian cancer patients

BMC Research Notes

Volumn 5, Issue , 2012, Pages

  Scholz, Christoph ^a   Heublein, Sabine ^b   Lenhard, Miriam ^b   Friese, Klaus ^b   Mayr, Doris ^b   Jeschke, Udo ^b  

^a HEINRICH HEINE UNIVERSITY   (Germany)

^b UNIVERSITY OF MUNICH   (Germany)

Author keywords

Glycodelin; Immunohistochemistry; Ovarian cancer; Prognosis

Indexed keywords

ANTIBODY; GLYCOPROTEIN; GONADOTROPIN RECEPTOR; MUCIN 1; PAEP PROTEIN, HUMAN; TUMOR MARKER;

ARTICLE; CANCER GRADING; CANCER STAGING; CARCINOMA; CHEMISTRY; FEMALE; GENE EXPRESSION; GENETICS; HUMAN; IMMUNOHISTOCHEMISTRY; METABOLISM; MORTALITY; NEOPLASM; OVARY TUMOR; PATHOLOGY; PROGNOSIS; SURVIVAL;

ANTIBODIES; CARCINOMA; FEMALE; GENE EXPRESSION; GLYCOPROTEINS; HUMANS; IMMUNOHISTOCHEMISTRY; MUCIN-1; NEOPLASM GRADING; NEOPLASM STAGING; NEOPLASMS; NEOPLASMS, GLANDULAR AND EPITHELIAL; OVARIAN NEOPLASMS; PROGNOSIS; RECEPTORS, GONADOTROPIN; SURVIVAL ANALYSIS; TUMOR MARKERS, BIOLOGICAL;

MLCS; MLOWN;

EID: 84875326634     PISSN: None     EISSN: 17560500     Source Type: Journal    
DOI: 10.1186/1756-0500-5-551     Document Type: Article

References (37)

1. Prognostic factors for patients treated for a recurrent FIGO stage III ovarian cancer: a retrospective study of 108 cases. Classe JM, Jaffre I, Frenel JS, Bordes V, Dejode M, Dravet F, Ferron G, Marchal F, Berton Rigaud D, Loussouarn D, Eur J Surg Oncol 2011 37 11 971 977 10.1016/j.ejso.2011.08.138 21944959
2. Survival effect of maximal cytoreductive surgery for advanced ovarian carcinoma during the platinum era: a meta-analysis. Bristow RE, Tomacruz RS, Armstrong DK, Trimble EL, Montz FJ, J Clin Oncol 2002 20 5 1248 1259 10.1200/JCO.20.5.1248 11870167 (Pubitemid 34177431)
3. Relapse and survival in early-stage ovarian cancer. Lenhard SM, Bufe A, Kumper C, Stieber P, Mayr D, Hertlein L, Kirschenhofer A, Friese K, Burges A, Arch Gynecol Obstet 2009 280 1 71 77 10.1007/s00404-008-0877-z 19093129
4. Glycodelin-A as a paracrine regulator in early pregnancy. Lee CL, Lam KK, Koistinen H, Seppala M, Kurpisz M, Fernandez N, Pang RT, Yeung WS, Chiu PC, J Reprod Immunol 2011 90 1 29 34 10.1016/j.jri.2011.04.007 21641661
5. Functional characterization of the progestagen-associated endometrial protein gene in human melanoma. Ren S, Liu S, Howell PM Jr, Zhang G, Pannell L, Samant R, Shevde-Samant L, Tucker JA, Fodstad O, Riker AI, J Cell Mol Med 2010 14 6B 1432 1442 19799645
6. Glycodelin A induces a tolerogenic phenotype in monocyte-derived dendritic cells in vitro. Scholz C, Toth B, Brunnhuber R, Rampf E, Weissenbacher T, Santoso L, Friese K, Jeschke U, Am J Reprod Immunol 2008 60 6 501 512 10.1111/j.1600-0897.2008.00647.x 19032611
7. Glycoprotein and carbohydrate binding protein expression in the placenta in early pregnancy loss. Jeschke U, Toth B, Scholz C, Friese K, Makrigiannakis A, J Reprod Immunol 2010 85 1 99 105 10.1016/j.jri.2009.10.012 20299109
8. Correlation between symptoms of pain and peritoneal fluid inflammatory cytokine concentrations in endometriosis. Scholl B, Bersinger NA, Kuhn A, Mueller MD, Gynecol Endocrinol 2009 25 11 701 706 10.3109/09513590903159680 19903048
9. Serum glycodelin pattern during the menstrual cycle in healthy young women. Bersinger NA, Birkhauser MH, Yared M, Wunder DM, Acta Obstet Gynecol Scand 2009 88 11 1215 1221 10.3109/00016340903294264 19900139
10. The role of glycodelin in cell differentiation and tumor growth. Koistinen H, Hautala LC, Seppala M, Stenman UH, Laakkonen P, Koistinen R, Scand J Clin Lab Invest 2009 69 4 452 459 10.1080/00365510903056023 19551557
11. Ovarian cancer-derived glycodelin impairs in vitro dendritic cell maturation. Scholz C, Rampf E, Toth B, Brunnhuber R, Weissenbacher T, Friese K, Jeschke U, J Immunother 2009 32 5 492 497 10.1097/CJI.0b013e3181a59fa9 19609241
12. New soluble placental tissue proteins: their isolation, characterization, localization and quantification. Bohn H, Kraus W, Winckler W, Placenta Suppl 1982 4 67 81 6085895
13. Glycodelin from seminal plasma is a differentially glycosylated form of contraceptive glycodelin-A. Koistinen H, Koistinen R, Dell A, Morris HR, Easton RL, Patankar MS, Oehninger S, Clark GF, Seppala M, Mol Hum Reprod 1996 2 10 759 765 10.1093/molehr/2.10.759 9239694 (Pubitemid 126717528)
14. Development of monoclonal and polyclonal antibodies and an ELISA for the determination of glycodelin in human serum, amniotic fluid and cystic fluid of benign and malignant ovarian tumors. Jeschke U, Bischof A, Speer R, Briese V, Richter DU, Bergemann C, Mylonas I, Shabani N, Friese K, Karsten U, Anticancer Res 2005 25 3A 1581 1589 16033064 (Pubitemid 40896768)
15. Development and characterization of monoclonal antibodies for the immunohistochemical detection of glycodelin A in decidual, endometrial and gynaecological tumour tissues. Jeschke U, Kuhn C, Mylonas I, Schulze S, Friese K, Mayr D, Speer R, Briese V, Richter DU, Haase M, Histopathology 2006 48 4 394 406 10.1111/j.1365-2559.2006.02351.x 16487361
16. [Recommendation for uniform definition of an immunoreactive score (IRS) for immunohistochemical estrogen receptor detection (ER-ICA) in breast cancer tissue]. Remmele W, Stegner HE, Pathologe 1987 8 3 138 140 3303008
17. Opposed roles of follicle-stimulating hormone and luteinizing hormone receptors in ovarian cancer survival. Lenhard M, Lennerova T, Ditsch N, Kahlert S, Friese K, Mayr D, Jeschke U, Histopathology 2011 58 6 990 994 10.1111/j.1365-2559.2011.03848.x 21585434
18. Human chorionic gonadotropin and its relation to grade, stage and patient survival in ovarian cancer. Lenhard M, Tsvilina A, Schumacher L, Kupka M, Ditsch N, Mayr D, Friese K, Jeschke U, BMC Cancer 2012 12 1 2 10.1186/1471-2407-12-2 22214378
19. Glycodelin expression associates with differential tumour phenotype and outcome in sporadic and familial non-BRCA1/2 breast cancer patients. Hautala LC, Greco D, Koistinen R, Heikkinen T, Heikkila P, Aittomaki K, Blomqvist C, Koistinen H, Nevanlinna H, Breast Cancer Res Treat 2011 128 1 85 95 10.1007/s10549-010-1065-y 20676758
20. Immunolocalization of glycodelin in human adenocarcinoma of the lung, squamous cell carcinoma of the lung and lung metastases of colonic adenocarcinoma. Kunert-Keil C, Steinmuller F, Jeschke U, Gredes T, Gedrange T, Acta Histochem 2011 113 8 798 802 10.1016/j.acthis.2010.11.009 21168900
21. Glycodelin in ovarian serous carcinoma: association with differentiation and survival. Mandelin E, Lassus H, Seppala M, Leminen A, Gustafsson JA, Cheng G, Butzow R, Koistinen R, Cancer Res 2003 63 19 6258 6264 14559812 (Pubitemid 37255172)
22. Structural analysis of the oligosaccharides derived from glycodelin, a human glycoprotein with potent immunosuppressive and contraceptive activities. Dell A, Morris HR, Easton RL, Panico M, Patankar M, Oehniger S, Koistinen R, Koistinen H, Seppala M, Clark GF, J Biol Chem 1995 270 41 24116 24126 10.1074/jbc.270.41.24116 7592613
23. Immunohistochemistry, glycosylation and immunosuppression of glycodelin in human ovarian cancer. Jeschke U, Mylonas I, Kunert-Keil C, Stahn R, Scholz C, Janni W, Kuhn C, Schroder E, Mayr D, Friese K, Histochem Cell Biol 2009 131 2 283 295 10.1007/s00418-008-0510-z 18853174
24. Ovarian cancer cytoreduction induces changes in T cell population subsets reducing immunosuppression. Napoletano C, Bellati F, Landi R, Pauselli S, Marchetti C, Visconti V, Sale P, Liberati M, Rughetti A, Frati L, J Cell Mol Med 2010 14 12 2748 2759 10.1111/j.1582-4934.2009.00911.x 19780872
25. Ovarian epithelial tumor growth promotion by follicle-stimulating hormone and inhibition of the effect by luteinizing hormone. Zheng W, Lu JJ, Luo F, Zheng Y, Feng Y, Felix JC, Lauchlan SC, Pike MC, Gynecol Oncol 2000 76 1 80 88 10.1006/gyno.1999.5628 10620446 (Pubitemid 30048324)
26. Expression of gonadotropin and activin receptor messenger ribonucleic acid in human ovarian epithelial neoplasms. Minegishi T, Kameda T, Hirakawa T, Abe K, Tano M, Ibuki Y, Clin Cancer Res 2000 6 7 2764 2770 10914722 (Pubitemid 30482116)
27. Glycodelin protein and mRNA is downregulated in human first trimester abortion and partially upregulated in mole pregnancy. Toth B, Roth K, Kunert-Keil C, Scholz C, Schulze S, Mylonas I, Friese K, Jeschke U, J Histochem Cytochem 2008 56 5 477 485 10.1369/jhc.2008.950600 18256018 (Pubitemid 351556490)
28. Stimulation of hCG protein and mRNA in first trimester villous cytotrophoblast cells in vitro by glycodelin A. Jeschke U, Karsten U, Reimer T, Richter DU, Bergemann C, Briese V, Mylonas I, Friese K, J Perinat Med 2005 33 3 212 218 15914343 (Pubitemid 41069862)
29. Evaluation of a novel anti-mucin 1 (MUC1) antibody (PankoMab) as a potential diagnostic tool in human ductal breast cancer; comparison with two established antibodies. Dian D, Janni W, Kuhn C, Mayr D, Karsten U, Mylonas I, Friese K, Jeschke U, Onkologie 2009 32 5 238 244 10.1159/000209280 19420969
30. The induction of baboon glycodelin expression by progesterone is not through Sp1. Jaffe RC, Donnelly KM, Fazleabas AT, Mol Hum Reprod 2003 9 1 35 40 10.1093/molehr/gag008 12529418 (Pubitemid 36285141)
31. Increased glycodelin levels in gynecological malignancies. Horowitz IR, Cho C, Song M, Flowers LC, Santanam N, Parthasarathy S, Ramachandran S, Int J Gynecol Cancer 2001 11 3 173 179 10.1046/j.1525-1438.2001.01017.x 11437921 (Pubitemid 32622662)
32. Expression of the glycodelin A gene and the detection of its protein in tissues and serum of ovarian carcinoma patients. Richter C, Baetje M, Bischof A, Makovitzky J, Richter DU, Gerber B, Briese V, Anticancer Res 2007 27 4A 2023 2025 17649816 (Pubitemid 46954719)
33. [Molecular pathology of epithelial ovarian neoplasias: from the phenotype-genotype correlation to new targets in diagnostics and therapy]. Staebler A, Diebold J, Pathologe 2007 28 3 180 186 10.1007/s00292-007-0910-1 17431628 (Pubitemid 46902944)
34. Glycodelin gene expression in human peripheral white blood cells. Lang EE, Venkatraman G, Ir J Med Sci 2007 176 2 101 104 10.1007/s11845-007-0019-9 17570010 (Pubitemid 46952280)
35. Habitual abortion is accompanied by low serum levels of placental protein 14 in the luteal phase of the fertile cycle. Tulppala M, Julkunen M, Tiitinen A, Stenman UH, Seppala M, Fertil Steril 1995 63 4 792 795 7890064
36. Endometrial protein PP14 and CA-125 in recurrent miscarriage patients; correlation with pregnancy outcome. Dalton CF, Laird SM, Estdale SE, Saravelos HG, Li TC, Hum Reprod 1998 13 11 3197 3202 10.1093/humrep/13.11.3197 9853880 (Pubitemid 28521874)
37. Glycodelin: a novel serum anti-inflammatory marker in type 1 diabetic retinopathy during pregnancy. Loukovaara S, Immonen IR, Loukovaara MJ, Koistinen R, Kaaja RJ, Acta Ophthalmol Scand 2007 85 1 46 49 17244209 (Pubitemid 46140155)